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ABSTRACT
Introduction 
Multimorbidity, commonly defined as having two or more chronic conditions, is a major 
burden in middle-aged and older adults, causing increased risks for hospitalizations, 
medical care costs, and even death. One condition with severe adverse effects in the 
older population is depression. Depression has been shown to increase ones social 
isolation while compounding self-management, eventually increasing ones chance for 
mortality. Multimorbidity coupled with depression has been shown to increase the risk 
for mortality; however, these results are typically based on a one-time depression 
evaluation. The main objective of this study is to examine if depressive symptom 
trajectories modifies the effect multimorbidity has on all-cause and cause-specific 
(cancer and cardiovascular disease) mortality. 
Methods 
Data obtained from the Health and Retirement Study (HRS) was used for this study. A 
multimorbidity variable was created using data from the 2004 wave of the HRS. Three 
distinct depressive symptom trajectories were created using the biennial waves from 
1998, 2000, 2002, and 2004 (persistently low, persistently moderate, and persistently 
high). Deaths were analyzed and categorized from the 2006, 2008, 2010, 2012, and 2014 
datasets. Confounders were analyzed in 2004 and were included based on their 
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presence in similar studies. There were a total of 13005 individuals aged 50 and older 
who fit the criteria for this study. Separate Cox proportional hazards models were 
created and ran to examine the association depressive symptom trajectories have on 
modifying the effect multimorbidity has on all-cause and cancer mortality. Fine and Gray 
models were created and ran to examine the association depressive symptom 
trajectories have on modifying the effect multimorbidity has on cardiovascular disease 
(CVD) mortality.  
Results 
From the final study population, 58.5% had persistently low depression symptoms, 
24.9% had persistently moderate depression symptoms, and 16.6% had persistently 
high depression symptoms. We found depressive symptom trajectories to significantly 
modify the association between multimorbidity and cardiovascular mortality, 
specifically among individuals who had three or more chronic conditions. The greatest 
risk of cardiovascular death was among individuals who had three or more chronic 
conditions and had persistently high depressive symptom trajectories (HR: 1.85; 95% CI: 
1.22, 2.79). Depressive symptom trajectories did not significantly modify the association 
between multimorbidity and all-cause or cancer mortality. 
Conclusion 
The findings from this study found that depressive symptom trajectories did not modify 
the risk of all-cause or cancer-mortality in multimorbid individuals. Depressive symptom 
trajectories did modify the association between multimorbidity and cardiovascular 
vii 
mortality. Findings from this study partially suggest that depressive symptom 
trajectories may help to further stratify people who are at a higher risk for CVD 
mortality. More studies need to be conducted to see if depressive symptom trajectories 
modify the risk of death in all-cause and cancer-mortality when taking into account the 
combination of diseases and the severity of the illness. Managing individuals with 
persistent depressive symptoms and comorbid diseases should be explored to see if 
properly managing these illnesses could mitigate the mortality effects seen. 
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CHAPTER 1 
INTRODUCTION
Middle-aged and older adults represent a sizable proportion of the U.S. 
population with complex health care needs including higher utilization of health care 
services, polypharmacy, frequent hospitalizations, and multimorbidity (Bodenheimer & 
Berry-Millet, 2009). The prevalence of multimorbidity, the presence of two or more 
conditions, ranges between 55% and 98% for middle-aged and older adults (Strauss et 
al., 2014; Ward, 2010). High levels of multimorbidity are associated with an increased 
risk of hospitalizations, deterioration of physical and cognitive health, higher medical 
care expenditures, and death (Moran et al., 2015; Quiῆones et al., 2011; Violan et al., 
2014). Despite an accumulation of research examining multimorbidity and mortality, the 
epidemiology and clinical course of multimorbidity remains poorly understood. 
 Depression is fairly common among middle-aged and older adults with multiple 
chronic conditions (Rote, Chen, & Markides, 2015; Sinnige et al., 2013). Depression may 
lead to increased social isolation, compound self-management by preventing one from 
being adherent to medication and behavioral lifestyles (i.e., physical activity), and 
activate the hypothalamic-pituitary-adrenal axis (HPA) which is associated with adverse 
health outcomes (i.e., cardiovascular disease programming) (Barth, Schumacher, & 
Herrmann-Lingen, 2004; van Dooren et al., 2013; Pinquart & Duberstein, 2010; Xiong & 
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Zhang, 2013). The combination of multimorbidity and depression may lead to a 
heightened vulnerability for death (Mezuk & Gallo, 2013). Several prior studies have 
identified depression as a significant risk factor for all-cause mortality, cardiovascular, 
cancer, and diabetic mortality (Barth, Schumacher, & Herrmann-Lingen, 2004; van 
Dooren et al., 2013; Pinquart & Duberstein, 2010). ] However, the few studies reporting 
a significant association between multimorbidity, depression, and mortality, examined 
depression only at a single point in time. Depressive symptoms are dynamic (Gilsanz et 
al., 2015). The course of depressive symptoms may vary over time, with fluctuating 
severity or the remitting and relapsing nature of symptoms (Musliner et al., 2016). 
Increasingly, longitudinal patterns of depressive symptoms (i.e. trajectories) are studied 
in older adults (Andreescu et al., 2008; Byers et al., 2012; Hsu, 2012; Hybels et al., 2016; 
Kuchibhatla et al., 2012; Kuo et al., 2011; Liang et al., 2011; Montagnier et al., 2014;). 
However, little is known about the potential heterogeneity in the relationship between 
multimorbidity and mortality by depression symptom trajectories. 
 Targeted and treating long-term depression among middle-aged and older adults 
may provide an opportunity to reduce all-cause and cause-specific mortality. However, 
our understanding of these mechanisms is limited and a more detailed study of the 
relationship between multimorbidity, depressive symptoms trajectories, and mortality is 
warranted. The overall objective of this study was to assess the longitudinal association 
between multimorbidity and depressive trajectories on all-cause mortality among a 
multi-ethnic community-dwelling sample of middle aged and older adults from 1998-
3 
2014, using data from the Health and Retirement Study (HRS). The following question 
was explored: 
 Question 1: Do depressive symptom trajectories modify the association between 
multimorbidity status and all-cause and cause-specific (cardiovascular and cancer) 
mortality? 
 Hypothesis 1: It is hypothesized that high-risk depressive symptom trajectories 
will be associated with an increased risk of all-cause mortality in comparison to low-risk 
depressive symptom trajectories. 
 Hypothesis 2: It is hypothesized that high-risk depressive symptom 
trajectories will be associated with cardiovascular and cancer mortality in comparison to 
low-risk depressive symptom trajectories.
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CHAPTER 2 
LITERATURE REVIEW
Multimorbidity 
 Multimorbidity is popularly defined as the co-existence of two or more chronic 
conditions (Barnett et al., 2012; Fortin et al., 2004; Salive, 2013; Uijen & Lisdonk, 2008; 
Van den Akker et al., 1998). The number of chronic conditions a person is diagnosed 
with has been shown to increase with age (Barnett et al., 2012; Glynn et al., 2011; 
Salive, 2013). Current multimorbidity prevalence is estimated to range from 65-98% in 
older adult populations, those aged 65 and older (Glynn et al., 2011). In the United 
States it is estimated that 81 million Americans will have more than two chronic 
conditions by 2020 (Fortin et al., 2005).  
 Multimorbidity has been shown to be associated with a wide variety of adverse 
health events including a decline in functional status, quality of life, and increasing 
health care costs and utilization (Glynn et al., 2011; Marengoni et al., 2011; Salive, 
2013). Studies from several different countries have found an increased risk of 
functional decline or disability in regards to increasing numbers of chronic diseases 
(Bayliss et al., 2004; Kadam & Croft, 2007; Loza et al., 2009; Marengoni et al., 2009; 
Marengoni et al., 2011). For both longitudinal and cross-sectional studies participants’ 
functional status was ascertained by asking about necessary activities of daily living 
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including questions regarding bathing, walking, dressing, eating, and using the toilet 
(Bayliss et al., 2004; Kadam & Croft, 2007; Loza et al., 2009; Marengoni et al., 2009). 
Some have hypothesized the clinical course, severity, and treatment type of these 
conditions could affect the rate of decline in older adults (Bayliss et al., 2004; Marengoni 
et al., 2009).  
 Multimorbidity has also been shown to have negative effects on quality of life. 
The current literature shows an inverse association regarding the number of chronic 
conditions one has and their quality of life (Byles et al., 2005; Chen, Baumgardner, & 
Rice, 2007; Loza et al., 2009; Walker, 2007). Quality of life commonly incorporates a 
person’s perceived physical, mental, and social well-being over time (Chen, 
Baumgardner, & Rice, 2007). A person’s perceived health status and quality of life has 
been documented to predict all-cause mortality, disease-specific morbidity, and 
functional decline; therefore causing room for concern when dealing with patients who 
have multiple chronic conditions (Bayliss, Ellis, & Steiner, 2007). An individual’s self-
management, self-care, and lack of a support system could hasten the decline of their 
perceived quality of life (Bayliss, Ellis, & Steiner, 2007).  
Health care costs and utilization is another consequence to having multiple 
chronic conditions. The number of chronic conditions one has is strongly associated with 
increased healthcare costs, number of medications, and hospital admissions (Condelius 
et al., 2008; Glynn et al., 2011; Laux et al., 2008; Marengoni et al., 2011; Schneider, 
O’Donnell, & Dean, 2009; Wolff, Starfield, & Anderson, 2002). A large study looking at 
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Medicare recipients showed two thirds of the beneficiaries had multiple chronic 
conditions yet accounted for 95% of the Medicare expenditures (Wolff, Starfield, & 
Anderson, 2002). This spike in healthcare costs, medication prescriptions, and 
admissions could be due to the complexity of care one receives as the number of 
conditions increases (Schneider, O’Donnell, & Dean, 2009). Those who have multiple 
diagnoses potentially receive contradictory advice from multiple physicians and receive 
redundant services providing a challenge in managing these multiple ailments 
(Schneider, O’Donnell, & Dean, 2009). These adverse health events associated with 
multimorbidity highlight the burden those with multiple chronic conditions face.  
Additionally, physicians have the problem of treating multiple conditions where one 
medication could improve one chronic illness while worsening another. 
 In addition to having studies highlighting the consequences associated with 
multimorbidity there is also well-documented literature on common chronic disease 
conditions that are found together in individuals. One study recently conducted looked 
at common dyads and triads of multiple chronic conditions across varying age groups 
and found there were distinct clusters of conditions (Ward & Schiller, 2013). The two 
most common dyads in both men and women aged 65 and older were ever having 
hypertension and arthritis and ever having diabetes and hypertension (Ward & Schiller, 
2013). In regards to the most common triads in men and women aged 65 and older ever 
having arthritis, diabetes, and hypertension was the highest followed by ever having 
arthritis, cancer, and hypertension (Ward & Schiller, 2013). While diabetes and 
hypertension were found to be highly clustered with other diseases, depression was 
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found to be the most commonly clustered ailment in a similar study (Sinnige et al., 
2013). Similarly this study also concluded hypertension, diabetes, and coronary artery 
disease had a high prevalence of clustering among one another (Sinnige et al., 2013). 
Finally, another study looked at patients who had Alzheimer’s disease and found 
congestive heart failure, chronic obstructive pulmonary disease, diabetes, and cancer 
were all clustered together (Vogeli et al., 2007). While these results show high rates of 
hypertension and diabetes there are also stark differences. This gives room for more 
research to be conducted in comorbid clustering but does give evidence to support the 
high amounts of multimorbidity in populations.  
Multimorbidity and Mortality in Older Adults 
 Increased healthcare costs, disability, and quality of life are all adverse health 
effects of multimorbidity, however, the increased risk of mortality is also well 
documented and of major concern. Many studies have shown that an increase in 
multiple chronic conditions increases one’s risk of mortality, especially in older 
populations (Gijsen et al., 2001; Loprinzi, Addoh, & Joyner, 2016; Marengoni et al., 2011; 
Menotti et al., 2001; St John et al., 2014). The studies that examined the association 
multimorbidity had on mortality were in a variety of locations and had varying follow up 
times; however, the point remained that the presence of multimorbidity significantly 
increased one’s risk of mortality (Gijsen et al., 2001; Loprinzi, Addoh, & Joyner, 2016; 
Marengoni et al., 2011; Menotti et al., 2001; St John et al., 2014).  
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Measuring Multimorbidity  
While the literature is robust in the consequences multimorbidity is associated 
with the measurement and classification of multimorbidity is not as well documented. 
Multimorbidity is commonly measured through a simple disease count in individuals or 
through weighted indices (Charleson Index, Elixhauser) that assess the burden of 
morbidity over a broad range of conditions (Diederichs, Berger, & Bartels, 2011; Huntley 
et al., 2012; Kadam & Croft, 2007).  These popular methods come with their own 
advantages and disadvantages. A basic disease count is the most common way to 
measure multimorbidity and involves summing the number of conditions one has from 
either self-reported, physician-reported, or medically recorded data (Huntley et al., 
2012). While data on disease counts and types of diseases is typically readily available it 
is hard to compare between studies due to the varying number of conditions included 
for analysis (Huntley et al., 2012). In recent systematic reviews the number of conditions 
studied ranged from 4 to 102 different conditions (Diederichs, Berger, & Bartels, 2011; 
Fortin et al., 2012; Harrison et al., 2014). Additionally, most disease counts are based on 
summing up all chronic conditions but chronicity is seldom defined (Huntley et al., 
2012). Even among the multimorbidity literature there is a wide range of how 
investigators group the number of conditions one has for analysis. For example, some 
authors categorize multimorbidity as a binary outcome, no multimorbidity vs 
multimorbidity (Bähler et al., 2015; Landi et al., 2010; Sharkey, 2003). However, others 
classify multimorbidity according to varying disease counts; ranging from low 
multimorbidity status (2-3 conditions) to high (6+ conditions) or to other 
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predetermined, relevant disease count groups (Fung et al., 2008; Glynn et al., 2011; 
Kadam & Croft, 2007; Menotti et al., 2001; St John et al., 2014). This heterogeneity in 
disease count classification reinforces the limitation in using disease count data. This 
study aims to capture specific populations who are at a higher risk of mortality based on 
the number of chronic conditions they have.  
Another common way to measure multimorbidity is through weighted indices 
(Diederichs, Berger, & Bartels, 2011; Huntley et al., 2012). While there have been 
several indices created to measure multimorbidity the “Charlson Index” is the most 
frequently used (Diederichs, Berger, & Bartels, 2011). This index was created to use in 
longitudinal studies to allow investigators to classify comorbid conditions in evaluating 
prognoses, specifically mortality (Charlson et al., 1987; Diederichs, Berger, & Bartels, 
2011; Huntley et al., 2012; Needham et al., 2005). This index provides a means for 
investigators to assess the number of chronic conditions and their severity by looking at 
the number of diseases a patient has multiplied by the relative mortality risk weight 
(Charlson et al., 1987 Diederichs, Berger, & Bartels, 2011). For example, congestive 
heart failure receives a mortality risk weight of one, whereas a metastatic solid tumor 
receives a mortality risk weight of six (Needham et al., 2005). Since the time the 
Charlson Index was first created there have been multiple versions created, differing in 
the number of disease categories (Huntley et al., 2012). Since this measure has been 
around for 30 years it has since been validated in an array of settings (Huntley et al., 
2012). Another advantage to using this index is it can be calculated from readily 
available data (Huntley et al., 2012). However, in a recent systematic review it was 
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found that simpler methods, such as disease counts, were just as predictive in mortality 
and other healthcare outcomes (Huntley et al., 2012). 
 These two primary ways of classifying and measuring multimorbidity do an 
adequate job at examining the association multimorbidity has on health outcomes, 
however, more research is warranted to see if there are valid disease cut-points to be 
used as well as the number of comorbid conditions to be included in the analysis.  
Depression in Older Adults 
 The World Health Organization defined depression as a common mental disorder 
which can be characterized by sadness, loss of interest or pleasure, feelings of guilt or 
low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor 
concentration (Depression). Major depressive disorder estimates vary for older adults, 
aged 65 and older, with estimates ranging from 1-5% to 15-19% (Cahoon, 2012; Fiske, 
Wetherell, & Gatz, 2009). However, the risks of a major depressive disorder have been 
shown to increase with age; as older adults 75 and older have estimates between 5-9% 
(Rodda, Walker, & Carter, 2011). While the estimates for major depressive disorder vary 
there is a consensus of a higher prevalence of older adults who experience clinically 
significant depressive symptoms, ranging from 5-37% (Fiske, Wetherell, & Gatz, 2009; 
Rodda, Walker, & Carter, 2011). Additionally, these approximations were amplified 
when looking at older adults who resided in long-term care facilities with a range of 
having major depressive disorder or experiencing clinically relevant depressive 
symptoms to be between 14-44% (Cahoon, 2012; Jones, Marcantonio, & Rabinowitz, 
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2003; Teresi et al., 2001; Thakur & Blazer, 2008). However, these results could be 
heightened by older adults who are undiagnosed or untreated (Barbour & Blumenthal, 
2005; Barg et al., 2006; Rodda, Walker, & Carter, 2011). Depression recognition and 
management is of utmost importance as the presence of depression increases ones risk 
for morbidity, suicide, disability, and healthcare utilization while decreasing ones 
physical, mental, and social functioning (Barbour & Blumenthal, 2005; Cahoon, 2012; 
Fiske, Wetherell, & Gatz, 2009; Rodda, Walker, & Carter, 2011). A recent meta-analysiss 
showed depression to be clustered with eight other diseases including hypertension, 
arthritis, diabetes mellitus, chronic obstructive pulmonary disease (COPD)/asthma, 
stroke, cancer, heart failure, and heart disease (Sinnige et al., 2013).  
Depression and Mortality 
 Research has shown that depression and depressive symptoms can significantly 
increase the risk of all-cause mortality for both men and women in older populations 
(Cuijpers & Smit, 2002; Mykletun et al., 2009; Saz et al., 2001). One study even 
controlled for a variety of behavioral and lifestyle risk factors that could mediate in the 
association, however, they still saw mortality to be significantly increased by depression 
by 37% (Mykletun et al., 2009).  
 According to the Centers for Disease Control and Prevention (CDC) 
cardiovascular disease is the leading cause of death for both men and women, where 
one in four deaths is from this disease (Heart Disease Facts, 2015). Cardiovascular 
disease already has a high mortality rate but research has shown that depression 
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increases this mortality rate (Barefoot et al., 1996; Barth, Schumacher, & Herrmann-
Lingen, 2004; Frasure-Smith et al., 2009; Schulz et al., 2000). The range of mortality was 
between 24-84%, with this showing an increase risk in mortality (Barefoot et al., 1996; 
Barth, Schumacher, & Herrmann-Lingen, 2004; Frasure-Smith et al., 2009; Schulz et al., 
2000). Depression was also shown to elevate mortality risk in patients who had suffered 
a myocardial infarction (Lespérance et al., 2002; Van Melle et al., 2004). Although the 
mechanism for why depression and cardiovascular disease heighten one’s risk for 
mortality there have been several plausible mechanisms proposed. One proposed 
mechanism is the lifestyle which is commonly associated with depressed patients: 
cigarette smokers, inactive, and hypertensive (Carney et al., 2002; Joynt, Whellan, & 
O’Connor, 2003). These risk factors are known to increase one’s chances of being 
diagnosed with cardiovascular disease. For example the relative risk of cardiovascular 
mortality associated with smoking an additional pack of cigarettes a day increases by 
39% (Joynt, Whellan, & O’Connor, 2003). An additional lifestyle factor hypothesized to 
increase cardiovascular mortality risk is the act of noncompliance that is commonly seen 
in depressed individuals (Carney et al., 2002; Joynt, Whellan, & O’Connor, 2003; Wang 
et al., 2002). Wang and colleagues conducted a study looking at antihypertensive 
medication use and found depressed individuals were more likely to be non-adherent 
compared to their non-depressed counterparts (Wang et al., 2002).  This lack of 
compliance could play a significant role in cardiovascular mortality. There have also 
been several proposed physiologic mechanisms examining the association between 
depressive symptom trajectories and cardiovascular mortality. 
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 Cancer is the second leading cause of death in the United States and will affect 
approximately 39% of men and women in their lifetime (Cancer Stat Facts: Cancer of any 
Site, n.d.; Leading Causes of Death, 2017). Many studies and meta-analyses have 
documented that depression significantly increased one’s cancer mortality risk (Giese-
Davis et al., 2010; Pinquart & Duberstein, 2010; Satin, Linden, & Phillips, 2009). In fact 
one randomized controlled trial found that decreased depression symptoms was 
associated with better survival compared to those with higher depression symptoms 
(Giese-Davis et al., 2010). A meta-analysis showed cancer patients who experienced 
depressed symptoms to have a 25% increased risk of mortality when looking at grouped 
relative risks (Satin, Linden, & Phillips, 2009). Depression was also found to accelerate 
disease progression in depressed cancer patients compared to non-depressed patients; 
potentially being one of the reasons depressed individuals have increased mortality 
rates (Sephton et al., 2009). They also found a stronger association of 39% in patients 
who had a mild or major depressive diagnosis (Satin, Linden, & Phillips, 2009). 
Additionally, depression is seen in cancer patients at higher rates compared to the 
general population, with oropharyngeal, pancreatic, breast, and lung cancers seeing 
higher rates of depression compared to other cancer types (Massie, 2002; Satin, Linden, 
& Phillips, 2009). One proposed mechanism is the dysregulation of cortisol levels which 
typically follow a circadian rhythm (Sephton et al., 2009; Spiegel & Giese-Davis, 2003; 
Weinrib et al., 2010). Typically, negative feedback should be present during night hours, 
however, in depressed individuals it has been shown not to be as active, causing the 
cortisol levels to be abnormal (Sephton et al., 2009; Weinrib et al., 2010). This abnormal 
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cortisol level has been shown to increase mortality risk and decrease functional 
disability (Sephton et al., 2009; Weinrib et al., 2010). 
  Although depression is a debilitating disease on its own, it has also been 
shown to be associated with a wide variety of morbidities and increased mortality rates. 
Therefore, it is imperative to find ways to combat depression’s negative effects so 
individuals are not losing precious time. 
Depressive Symptom Trajectories 
 In studies where depression is involved there are two common ways of 
measuring depression and its associated symptoms: a single baseline measurement or 
trajectories of symptoms over a specified period of time. Popularly, depression status is 
ascertained through a validated questionnaire where participants are commonly asked 
how often they experience certain depressive symptoms (Rao & Cohen, 2004). The 
Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale 
(GDS), and Beck Depression Inventory (BDI) are common tools used to determine 
depression status and symptoms in study subjects (Krebber et al., 2014; Rao & Cohen, 
2004; Shafer, 2006). By summing the responses to the questions provided the analyst 
can classify the participant based on predetermined cut-points for major, mild, some 
depressive symptoms, and no depression. These depression scales have shown to have 
both a sensitivity and specificity between 70-85%, strengthening the use of these 
measures in studies (Rao & Cohen, 2004). By only using one single measurement of 
depression, researchers are only able to gather information on a snapshot into the 
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participants’ mental state. A single depression measurement does not allow researchers 
to examine changes in depression status over time which could be an important factor 
in describing the association at hand (Sin, Yaffe, & Whooley, 2015). Additionally, single 
depression measurement does not capture intra-individual variability in symptoms 
which may have clinical importance as older adults experience different depression 
symptoms over time (Kaup et al., 2016). Finally, a single baseline measurement could 
underestimate the risk of depression. For example, someone could live with persistently 
high depression yet when they were surveyed their mood was positive; thus not 
accurately presenting their true symptoms.  
 Utilizing depressive symptom trajectories is becoming more robust in the 
literature (Gunn et al., 2013; Liang et al., 2011). Depression trajectories allow the 
investigator the see temporal changes of depression symptoms which could reflect the 
natural history of depression in the study population (Andreescu et al., 2008; 
Kuchibhatla et al., 2012; Rote, Chen, & Markides, 2015). Additionally, depression 
trajectories could be used to identify risk factors and certain outcomes associated with 
varying trajectories (Hsu, 2012; Musliner et al., 2016). Depressive symptom trajectories 
provide a more precise estimate over time and therefore allow for the identification of 
high risk groups (Kaup et al., 2016). To create depression trajectories researchers utilize 
the same tools (CES-D, GDS, BDI) used when only looking at baseline measurements of 
depression (Andreescu et al., 2008; Hsu, 2012; Kuchibhatla et al., 2012; Rote, Chen, & 
Markides, 2015). However, instead of collecting depression status at a single point in 
time trajectory methods systematically gather depression status periodically for a 
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specified period of time. After collecting this information latent growth curve analyses 
can be performed to identify the varying trajectories (Byers et al., 2012; Liang et al., 
2013; Rote, Chen, & Markides, 2015). Although the use of depression trajectories has 
many advantages it still has several limitations. One limitation is the trajectories are 
dependent on the frequency of data collection involving depression status, and since 
collection typically occurs annually or biannually there are still potential gaps left in 
understanding the natural history (Rote, Chen, & Markides, 2015). Depression status is 
typically determined through self-report, not a clinical diagnosis, and this self-reporting 
could skew the trajectories slightly (Andreescu et al., 2008; Kuchibhatla et al., 2012). 
However, the advantages of this method outweigh the limitations and should therefore 
be used in research when looking at depression influences. The use of depressive 
symptom trajectories can be more informative than a traditional, single measurement, 
as depressive symptom trajectories can identify high risk groups. Upon identification of 
high risk groups depression management programs can be targeted to treat these 
individuals.   
Depression Management among Multimorbid Individuals 
 Individuals who have depression coupled with multiple chronic conditions have 
been shown to have more adverse health outcomes and increased mortality rates. 
However, could depression management mitigate some of these negative outcomes? 
Four randomized controlled trials found that depression management could reduce 
adversary effects in multimorbid individuals, including a decrease in mortality rate 
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(Bogner & de Vries, 2008; Gallo et al., 2016; Harrison et al., 2012; Katon et al., 2010). 
Management programs included individual and group sessions aimed at educating the 
individual on depression, chronic conditions, and healthy lifestyle factors (diet, 
exercise), as well as collaborating with a medical team to come up with the best 
medication regimen with ample follow-up time to provide information on the 
individual’s progress and adherence to the program (Bogner & de Vries, 2008; Gallo et 
al., 2016; Harrison et al., 2012; Katon et al., 2010). In the trials listed significant 
reductions were seen in depressive symptoms, blood pressure readings, cholesterol 
levels, mortality rates, and increased quality of life, and well-being (Bogner & de Vries, 
2008; Gallo et al., 2016; Harrison et al., 2012; Katon et al., 2010). The results from these 
randomized controlled trials show promising benefits in reducing adverse outcomes 
depression can have on chronic diseases. 
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CHAPTER 3 
METHODS
Data Source: 
 The data is from the Health and Retirement Study which is a longitudinal biennial 
survey of a nationally representative sample of U.S. adults aged 50 and older that 
collects detailed information on physical health and functioning, cognition, disability, 
socioeconomic factors, and health care expenditures. The Health and Retirement study 
was sponsored by the National Institute of Aging and was conducted by the Institute of 
for Social Research at the University of Michigan (Sonnega et al., 2014). Data collection 
began in 1992 and is ongoing. The response rate was 81.4% in 1992 and was between 
85% and 90% in the following waves (Heeringa & Connor, 1995; Juster & Suzeman, 
1995, Sonnega et al., 2014). Detailed information concerning the sample design, 
recruitment, response rates, and measurement validation are discussed extensively 
elsewhere (Heeringa & Connor, 1995; Juster & Suzeman, 1995, Sonnega et al., 2014). 
HRS provides sampling weights for the data sets and there is an oversampling of African 
Americans and Hispanics, at about twice the rate of White respondents (Sonnega et al., 
2014).  
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Study Population 
 This study used data from the Health and Retirement Study (HRS), primarily 
utilizing the biennial waves from the years 1998, 2000, 2002, 2004, 2006, 2008, 2010, 
2012, and 2014. The RAND files were utilized which are a cleaned and processed version 
with consistent variable names (St Clair et al., 2002). Individuals were excluded if they 
were younger than 50 years old or had missing information regarding the depression 
symptom trajectories. Individuals who did not provide information on all eight chronic 
disease statuses were also excluded from the analysis. 192 individuals were excluded 
from the analysis because they were younger than 50. Additionally, 88 individuals were 
excluded from the analysis because they did not provide responses on all of the eight 
chronic diseases in question. After the exclusions of the 280 participants, the final 
analytic study population was 13005. 
Measurement of Variables 
Exposure Variable 
 Multimorbidity was the main exposure for this study. Multimorbidity was 
operationalized based on the self-report of eight chronic conditions. Chronic disease 
status was collected based on self-report and ascertained by asking respondents, “Has a 
doctor ever told you that you have high blood pressure or hypertension”. Eight chronic 
conditions were used for analysis: high blood pressure, diabetes mellitus, cancer 
(excluding cancer of the skin), lung disease, heart disease, stroke, psychiatric problems, 
and arthritis. The total number of conditions was summed across all participants who 
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indicated yes to a condition, giving a maximum score of eight chronic conditions. Similar 
to prior studies, the number of chronic conditions was categorized as: 0, 1, 2, and 3+ 
(Menotti et al., 2001; Wong et al., 2008). When analyzing cancer, diabetes, and 
cardiovascular mortality the groupings were 1, 2, and 3+ to account for the small sample 
sizes in the groups.  
Outcome Variable 
 All-cause mortality was the main outcome of interest for this study. Deaths 
occurring from 2006-2014 were assessed and included in the analysis. Updates on vital 
status were recorded at each biennial wave. If a death was reported, an exit interview 
was conducted with the spouse or closest relative of the deceased to ascertain timing, 
medical expenditures, and cause of death (Sonnega et al., 2014). Secondary outcomes 
included cause-specific mortality outcomes: cardiovascular diseases, cancer, and 
diabetes mellitus. All mortality outcomes will be assessed 2006-2014.  
 Cardiovascular and circulatory diseases were grouped using previously validated 
administrative claims-based algorithms of International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) codes for chronic rheumatic heart diseases 
(393-398), hypertensive diseases (401-405), ischemic heart diseases (410-414), diseases 
of pulmonary circulation (415-417), other forms of heart disease (420-429), 
cerebrovascular diseases (430-438), diseases of the arteries, arterioles, and capillaries 
(440-448), and diseases of veins and lymphatics, and other diseases of the circulatory 
system (451-459) (American Medical Association, 2004). 
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 Cancer was also be grouped using previously validated administrative claims-
based algorithms of ICD-9-CM codes for malignant neoplasms of lip, oral cavity, and 
pharynx (140-149), malignant neoplasms of digestive organs and peritoneum (150-159), 
malignant neoplasms of respiratory and intrathoracic organs (160-165), malignant 
neoplasms of bone, connective tissue, skin, and breast (170-175), Kaposi’s Sarcoma 
(176), malignant neoplasms of genitourinary organs (179-189), malignant neoplasms of 
other and unspecified sites (190-199), and malignant neoplasms of lymphatic and 
hematopoietic tissue (200-208) (American Medical Association, 2004). 
 As of 2010 these exit interviews, conducted by the Health and Retirement Study, 
had been conducted for 93% of deceased participants (Sonnega et al., 2014). The death 
records were verified through linkage between HRS data and the National Death Index 
or the Social Security Death Index (Sonnega et al., 2014). The month and year of death 
are recorded by the HRS to assign mortality status.  
Effect Modifier 
 Depressive symptom trajectories were created prior to this analysis in able to 
assess the hypothesis which suggested multimorbidity and all-cause mortality differed 
depending on course of depressive symptoms. The depressive symptom trajectories 
were created using HRS data from 1998-2004. The trajectories used in this analysis were 
created using the depressive symptoms which were measured using an 8-item version 
of the CES-D. HRS asked participants whether symptoms were experienced in the 
previous week (yes or no) to the following questions: felt depressed; felt that everything 
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I did was an effort; my sleep was restless; could not going; felt lonely; enjoyed life; felt 
sad; and was happy. Positive items were reverse coded. HRS created a variable for the 
summed depressive score for the participants. Reports of ≥3 symptoms were classified 
as having elevated depressive symptoms. This dichotomization of depressive symptoms 
threshold has been found to have high sensitivity and specificity and has been used in 
prior studies (Mondesir et al., 2015). All participants who were missing more than four 
items on the depressive scale were excluded from the analysis. The three trajectories 
that were used in this analysis are those among older adults with persistently high, 
persistently low depressive symptoms, persistently moderate depressive symptoms.  
Confounders 
In this analysis all confounders were assessed using the results from the 2004 
wave of the Health and Retirement Study, prior to any mortality analysis. The 
confounders used in this analysis have been previously identified in studies, thus 
supporting them to be included in this study (Gallo et al., 2016, Lin et al., 2009, Loprinzi, 
Addoh, & Joyner, 2016, Marengoni et al., 2009).  
Sex was analyzed and categorized as “male” and “female”.  
Age, in years, was analyzed using an HRS created variable. This already created 
variable was collected and included in the analysis as a continuous variable.  
Race and ethnicity was collected by asking two questions: “Do you consider 
yourself primarily White or Caucasian, Black or African American, American Indian, or 
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Asian, or something else” and “Do you consider yourself Hispanic or Latino”. Three 
mutually exclusive categories were created to be used for this analysis: “Non-Hispanic 
White”, “Non-Hispanic Black” and “Hispanic”.  
 Educational status was analyzed using a RAND created variable. This variable was 
created by combining the years of schooling and highest degree earned in a more 
general way. The RAND created categories were “less than high school”, “GED”, “high 
school graduate”, “some college”, and “college and above”. “High school graduate” 
included participants who reported 12 years of schooling exactly yet had no college 
degree. Those who were grouped into “some college” reported a response showing 
obtained a high school diploma or general educational development (GED) with more 
than 12 years of schooling. Respondents who reported earning a college degree, of 
Bachelor’s status or higher, were grouped in the category of “college and above”.  For 
analysis three education categories were created: less than a high school diploma, high 
school diploma, and greater than a high school diploma.  
Self-rated health was the participant’s self-reported general health status. The 
possible answers to how a participant rated their general health status are: “excellent”, 
“very good”, “good”, “fair”, and “poor”. For this analysis self-rated health was classified 
into two categories: fair-poor and good-excellent. 
Body Mass Index (BMI) was analyzed using a RAND created variable. This RAND 
created variable took the respondent’s height, in feet and inches, and converted it to 
meters. Likewise, the respondent’s weight, in pounds, was converted to kilograms. To 
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calculate each participant’s BMI the respondent’s weight, now in kilograms, was divided 
by their height in meters squared. The RAND created BMI was a continuous variable and 
was analyzed as a continuous variable for this analysis.  
Current smoking status was analyzed by asking participants if they currently 
smoked cigarettes. Respondents answered “yes” if they were a current smoker and “no” 
if they were not. For analysis these self-reported categories of “yes” and “no” will be 
utilized.  
Physical activity was obtained by asking participants three questions regarding 
their vigorous, moderate, and mild levels of physical activity intensity. To ascertain 
vigorous intensity physical activity, participants were asked, “How often do you take 
part in sports or activities that are vigorous, such as running or jogging, swimming, 
cycling, aerobics, or gym workout, tennis, or digging with a spade or shovel”. To gauge 
participants moderate intensity physical activity, participants were asked, “How often 
do you take part in sports or activities that are moderately energetic such as, gardening, 
cleaning the car, walking at a moderate pace, dancing, and floor or stretching exercises”. 
Finally, light intensity physical activity was ascertained by asking participants, “How 
often do you take part in sports or activities that are mildly energetic, such as 
vacuuming, laundry, and home repairs”. The response categories for each of the 
physical activity questions were “hardly ever or never”, “1 to 3 times per month”, “once 
per week”, “greater than once per week”, and “everyday”. Individual responses to the 
questions were weighted by intensity using an average metabolic equivalent of task 
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(MET) calculation (Latham & Williams, 2015).  Intensity responses were multiplied by 
their corresponding rates, 1.8 for vigorous, 1.4 for moderate, and 1.2 for light. The 
scores were then summed for all three intensity levels of physical activity, which 
produced a range from 0 to 17.6.  The thresholds used to determine physical activity 
intensity were: sedentary group (< 2.0); light intensity physical activity (>2.0 – 4.0); 
moderate physical activity (>4.0 – 8.0); and vigorous physical activity (>8.0). These cut 
points were based upon established MET thresholds (Latham & Williams, 2015).  
Statistical Analysis 
 Descriptive statistics were reported for all parametric study variables by 
multimorbidity grouping, with means and standard deviations calculated for continuous 
variables and frequencies and percentages computed for categorical variables. Variables 
that were nonparametric in nature were reported by multimorbidity grouping, with 
medians for continuous variables. Bivariate analyses were conducted to determine 
whether there were significant differences between multimorbidity classification and 
determined covariates.  
 The association between multimorbidity and all-cause mortality and cancer 
mortality were analyzed using Cox proportional hazards models. Cardiovascular 
mortality and diabetes mortality were analyzed using Fine and Gray models to account 
for any competing risks that could be present when analyzing these two causes of 
deaths. A competing risk is present when an individual is at risk for more than one 
mutually exclusive event, such as death from cardiovascular disease which will prevent 
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death from any other cause (diabetes) from occurring (Gondara, 2015). These 
competing risk models allowed for probabilities of death to be calculated even when 
there were competing risks present (Gondara, 2015). Prior to running any Cox 
proportional hazards models the proportionality assumption was tested to ensure this 
method was best in examining the association of interest. Depressive symptom 
trajectories were used to test the effect varying trajectories play on the three separate 
outcomes in question. Separate models were created for each of the outcomes of 
interest and included confounders based on prior studies concerning many of these 
variables as confounders in the association between multimorbidity and all-cause 
mortality (Landi et al., 2010, Loprinzi, Addoh, & Joyner, 2016, St John, Tyas, Menec, & 
Tate, 2014). Four models were generated to model all-cause and cause-specific 
mortality: Model 1 (Multimorbidity, survey year); Model 2 (Model 1 + age, sex, race, 
education); Model 3 (Model 2 + BMI, self-rated health, smoking status, physical activity 
level); and Model 4 (Model 3 + interaction term). A cross product term was included to 
account for each potential interaction in the model. Two sided p-values ≤.05 were 
considered statistically significant for all variables, including the interaction term. 
 Sampling weights were incorporated to account for the complex sampling 
design. All the data management functions and statistical analyses were performed 
using SAS version 9.4, Cary, NC, USA.  
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Sensitivity Analysis 
 A sensitivity analysis was performed to assess the distribution of the data looking 
at other chronic condition groupings, in comparison to the categorization proposed 
above. When analyzing the literature, there were several different ways to 
operationalize multimorbidity (Kleisiaris et al., 2016; Menotti et al., 2001; Villarreal et 
al., 2015; Wong et al., 2008). Appendix A. shows the distribution of chronic conditions in 
this population. This distribution coupled with the literature search helped determine 
the best way to operationalize multimorbidity.  
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CHAPTER 4 
RESULTS
The distribution of multimorbidity is provided (Table 4.1). Nearly 33% of the study 
population was diagnosed with three or more chronic conditions. Additionally, 28% of 
the study population was diagnosed and living with 2 chronic conditions. Approximately 
26% of the population had been diagnosed one chronic condition. Only 14% of the study 
population had not been diagnosed with one of the eight chronic conditions in question. 
 The distribution of socio-demographic and lifestyle factors by multimorbidity 
classification are listed in Table 4.2. The mean age for those individuals who had 0 
chronic conditions was 66.1 years. As the number of conditions one was diagnosed with 
increased so did the average age. The average age of study participants who had been 
diagnosed with one chronic condition (68.3 years), two chronic conditions (70.1 years), 
and three or more chronic conditions (71.7 years) was significantly older than those with 
0 chronic conditions (p-value <.0001 for all multimorbidity groupings). Individuals 
categorized as having 0 chronic conditions were more likely to be female (59.3%). The 
percentage of females was statistically higher in individuals who had one (62.3%, p-
value .0293), and two chronic conditions (63.1, p-value .0057) compared to those with 0 
chronic conditions. Individuals who had three or more chronic conditions saw an 
increase in the percentage of women; however, this difference was not statistically 
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significant when compared to individuals with 0 chronic conditions (61.9%, p-value 
.0504). Among individuals who had 0 chronic conditions more than four fifths were 
Whites (80.6%), less than one tenth were African American (9.0%), and one tenth were 
Hispanic (10.4%). However, the racial demographic significantly differed as the number 
of chronic conditions increased. The percentage of Whites decreased for individuals 
with two and three or more chronic conditions (79.7%, 78.2%), yet increased slightly in 
individuals with one chronic condition (81.6%). The percentage of Blacks increased for 
individuals with one, two, or three or more chronic conditions (11.0%, 13.5%, and 15.3% 
respectively). The Hispanic distribution decreased as the number of chronic conditions 
increased (7.4%, 6.7%, and 6.4% respectively). This change in the racial makeup was 
significantly different for all multimorbidity classifications. One chronic condition, two 
chronic conditions, and three or more conditions had a statistically significant racial 
distribution when compared to 0 chronic conditions (p-value .0002, p-value <.0001 and 
p-value <.0001, respectively). The majority of individuals who had only 0 chronic 
conditions had more than a high school diploma (49.8%) while one fifth of these 
individuals had less than a high school diploma (19.9%). As the number of chronic 
conditions increased so did the percentage of individuals who had less than a high 
school diploma. For individuals who had one chronic condition, over one fifth had not 
completed high school (20.9%), while 45.2% had more than a high school diploma. This 
was a significantly different breakdown of education compared to those with 0 chronic 
conditions (p-value .0060). Similarly, individuals who had two chronic conditions were 
more likely to have less than a high school diploma (24.8%), while approximately two 
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fifths had more than a high school diploma (40.1%). This breakdown was also 
significantly different from the breakdown of individuals with 0 chronic conditions (p-
value <.0001). Approximately one third of the individuals who had three or more 
chronic conditions had less than a high school diploma (34.6%), while one third had 
more than a high school diploma (34.0%). This breakdown of educational attainment 
was significantly different from the educational attainment of individuals with 0 chronic 
conditions (p-value <.0001). More than four fifths (84.3%) of individuals who had 0 
chronic conditions were non-smokers. Compared to individuals who had no chronic 
conditions, those with one chronic condition, saw a statistically significant increase in 
the percentage of non-smokers (87.0%, p-value .0075). Compared to individuals who 
had no chronic conditions, those with two (88.7, p-value <.0001) or three or more 
chronic conditions (87.4, p-value .0013), saw a statistically significant increase in the 
percentage of non-smokers. Over nine tenths (92.5%) of the individuals who had 0 
chronic condition rated their health as good, very good, or excellent. However, as the 
number of chronic conditions increased the perception of ones’ self-rated health 
decreased. Approximately 84.9% of individuals who had 1 chronic condition rated their 
health as good, very good, or excellent, this being significantly different from those 
individuals with 0 chronic conditions (p-value <.0001). Additionally, only about three 
fourths (74.9%) of individuals who had two chronic conditions rated their health as 
good, very good, or excellent; being statistically significant from those with 0-1 chronic 
conditions (p-value <.0001). Only 51.3% of individuals who had three or more chronic 
conditions rated their health as good, very good, or excellent. This was statistically 
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different than the percentage of self-rated health for individuals with 0 chronic 
conditions. Of the individuals who had 0 chronic conditions the majority engaged in 
vigorous physical activity (51.6%), approximately one third engaged in moderate 
intensity physical activity (36.4%), one tenth engaged in light intensity physical activity 
(9.7%), and 2.30% were sedentary. There were significant changes seen in physical 
activity levels as the number of chronic conditions increased to one, two, and three or 
more chronic conditions (p-value <.0001, p-value <.0001, p-value <.0001, respectively). 
Vigorous physical activity levels declined for those who had one, two, and three or more 
chronic conditions (44.6%, 35.1%, and 23.8%, respectively). Moderate intensity physical 
activity increased slightly among individuals who had one, two, and three or more 
chronic conditions (39.3%, 40.7%, and 38.8%, respectively). Light intensity physical 
activity saw increases in one, two, and three or more chronic conditions (11.3%, 16.9%, 
and 21.7%, respectively). Levels of sedentary behavior also increased for one, two, and 
three or more chronic conditions (4.9%, 7.3%, and 15.8%, respectively). Finally, the 
average BMI level for individuals with 0 chronic conditions was 25.7. BMI levels, for one, 
two, and three or more chronic conditions, saw significant increases (Averages: 26.6, 
27.5, and 28.7; p-values: <.0001, respectively).  
 Figure 4.1 depicts the breakdown of all-cause, cardiovascular, and cancer, 
mortality by multimorbidity grouping. Approximately 5.3% of the individuals who died 
from cardiovascular disease had 0 chronic conditions. Individuals who had 1 chronic 
condition saw 178 deaths, or approximately 13.2% of the total number of cardiovascular 
deaths. This was statistically more deaths than those who had 0 chronic conditions (p-
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value .0333). Similarly, individuals who had two chronic conditions saw about one fourth 
of the cardiovascular deaths (348 deaths, 25.8%). This was statistically more deaths than 
those with 0 chronic conditions (p-value <.0001). The greatest number of cardiovascular 
deaths occurred in individuals who had three or more chronic conditions (752 deaths, 
55.74). This was statistically more deaths than those who had 0 chronic conditions (p-
value <.0001). Around one tenth (8.3%) of the individuals who died from cancer had 0 
chronic conditions. Individuals who had one chronic condition saw 196 cancer deaths, or 
19.9% of the total number of cancer deaths. Although a greater number of deaths 
occurred, this was not statistically more deaths than those who had 0 chronic conditions 
(p-value .2646). There were 269 cancer deaths, or 27.3%, to occur in individuals who 
had two chronic conditions. This was statistically more cancer deaths compared to those 
who had 0 chronic conditions (p-value .0234). Individuals who had four or more chronic 
conditions and died from cancer had statistically more cases than those with 0 chronic 
conditions (439 cases, 44.5%; p-value .0003). 
 Figure 4.2 displays the distribution of depression status by the number of chronic 
conditions. There were significant changes seen in depression status as the number of 
chronic conditions increased from 0 chronic conditions to one, two, and three or more 
chronic conditions (p-value <.0001, p-value <.0001, p-value <.0001, respectively). 
18.13% of those who had persistently low depression had 0 chronic conditions. 
Persistently low depression levels increased from those with 0 chronic conditions to 
those with one, two, and three or more chronic conditions (30.0%, 28.25%, and 23.7%, 
respectively). 10.6% of the individuals with persistently moderate depression symptoms 
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had 0 chronic conditions. Persistently moderate depression symptoms increased among 
individuals who had one, two, and three or more chronic conditions (21.8%, 28.9%, and 
38.7%, respectively). Individuals who had 0 chronic conditions made up approximately 
5.1% of the population with persistently high depression symptoms. Persistently high 
depression symptoms saw drastic increases in one, two, and three or more chronic 
conditions (15.2%, 25.3%, and 54.4%, respectively).  
Figure 4.3 graphically presents the interaction between depression trajectories 
and multiple chronic conditions have on all-cause mortality. With 0 chronic conditions 
being the reference group, it is shown that having persistently low depression scores 
and one chronic condition has no increased risk for all-cause mortality (HR: 1.0; 95% CI: 
0.8, 1.2). Having two or three or more chronic conditions coupled with persistently low 
depression symptoms showed a slight increase in all-cause mortality, however, these 
results did not reach statistical significance (HR: 1.0 and 1.17; 95% CI: 0.848, 1.210 and 
0.980, 1.385, respectively). Having one or two chronic conditions coupled with 
persistently moderate depression symptoms led to a slight increase in all-cause 
mortality, however, these estimates did not reach statistical significance (HR: 1.146 and 
1.186; 95% CI: 0.849, 1.548 and 0.895, 1.571, respectively). Similarly, having three or 
more chronic conditions with persistently moderate depression pointed towards an 
increased risk for all-cause, yet this did not reach statistical significance (HR: 1.287; 95% 
CI: 0.981, 1.687). Having persistently high depression with multiple chronic conditions 
did not show of an increased risk for all-cause mortality. Having one chronic condition 
with persistently high depression scores only showed of a slight increase in the risk of 
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mortality, but failed to reach significance (HR: 1.058; 95% CI: 0.692, 1.618). Two and 
three or more chronic conditions with persistently high depression both showed an 
increase in the estimate for all-cause mortality, but failed to reach statistical significance 
(HR: 1.152 and 1.287; 95% CI: 0.775, 1.712 and 0.879, 1.885, respectively).  
 Figure 4.4 shows the adjusted associations of the interaction between 
depression trajectories and having multiple chronic conditions on cancer mortality. With 
one being the reference group, it is shown that having two or three or more chronic 
conditions coupled with persistently low depression scores leads to a slight increase in 
cancer mortality (HR: 1.072 and 1.094, respectively). However, both of these failed to 
reach statistical significance (95% CI: 0.844, 1.361 and 0.868, 1.378, respectively). 
Contrary to the results seen in persistently low depression scores, persistently moderate 
depression scores led to a slight decrease in cancer mortality rates for both two and 
three or more chronic conditions (HR: 0.945 and 0.836, respectively). These results 
however failed to reach statistical significance (95% CI: 0.650, 1.375 and 0.592, 1.181, 
respectively). Similarly, persistently high depression symptoms showed a slight decrease 
in cancer mortality rates for both two and three or more chronic conditions (HR: 0.868 
and 0.942, respectively). These results did not reach statistical significance (95% CI: 
0.511, 1.472 and 0.591, 1.501, respectively).  
 Figure 4.5 shows the adjusted associations between the interaction between 
depression trajectories and multiple chronic conditions on cardiovascular mortality. 
Individuals who had two chronic conditions and persistently low depression symptoms 
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saw an increase in cardiovascular mortality, however, this failed to reach significance 
(HR: 1.230, 95% CI: 0.985, 1.537). Individuals who had three or more chronic conditions 
and had persistently low depression symptoms saw a statistically significant increase in 
cardiovascular mortality compared to those with only one chronic condition (HR: 1.486; 
95% CI: 1.201, 1.839). Participants who had two chronic conditions and persistently 
moderate depression symptoms saw an increase in cardiovascular death, but lacked 
significance (HR: 1.416; 95% CI: 0.984, 2.038). Those with three or more chronic 
conditions and had persistently moderate depression symptoms saw a statistically 
significant increase in cardiovascular mortality compared to those who had one chronic 
condition (HR: 1.758, 95% CI: 1.260, 2.453). Similar to previous multiple chronic 
condition levels; individuals who had two chronic conditions with persistently high 
depression symptoms saw an increased risk for cardiovascular mortality, but failed to 
reach significance (HR: 1.223; 95% CI: 0.771, 1.940). Finally, individuals who had three or 
more chronic conditions and persistently high depression symptoms saw a statistically 
significant increase in cardiovascular mortality (HR: 1.847; 95% CI: 1.223, 2.789).  
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Table 4.1: Distribution of multimorbidity classification 
 
 N % 
0 Chronic Conditions 1833 14.09 
1 Chronic Condition 3319 25.52 
2 Chronic Conditions 3623 27.86 
3+ Chronic Conditions 4230 32.53 
Total 13005 100.00 
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Table 4.2: Baseline Characteristics by Multimorbidity Grouping: HRS 2004 
 
 0 Chronic Conditions 1 Chronic Condition 2 Chronic Conditions 3+ Chronic Conditions 
 N %, SD N %, SD P-Valuea N %, SD P-Valueb N %, SD P-Valuec 
Age (mean, SD) 66.10 8.75 68.33 9.20 <.0001d 70.14 9.13 <.0001 71.69 9.24 <.0001 
Gender     .0293   .0057   .0504 
     Male 747 40.75 1250 37.66  1337 36.90  1611 38.09  
     Female 1086 59.25 2069 62.34  2286 63.10  2619 61.91  
Race/Ethnicity     .0002   <.0001   <.0001 
     White 1438 80.961 2658 81.61  2850 79.72  3253 78.22  
     Black 161 9.02 359 11.02  484 13.54  638 15.34  
     Hispanic 185 10.37 240 7.37  241 6.74  268 6.44  
Education     .0060   <.0001   <.0001 
     Less than HS 365 19.91 695 20.94  899 24.81  1462 34.56  
     High School 556 30.33 1123 33.84  1271 35.08  1331 31.47  
     More than HS 912 49.75 1501 45.22  1453 40.10  1437 33.97  
Self-Rated Health     <.0001   <.0001   <.0001 
     Fair/Poor 137 7.47 502 15.13  909 25.11  2058 48.71  
     Good/Excellent 1696 92.53 2816 84.87  2711 74.89  2167 51.29  
Physical Activity     <.0001   <.0001   <.0001 
     Sedentary 42 2.30 162 4.89  263 7.27  666 15.76  
     LIPA 177 9.68 375 11.31  613 16.93  917 21.70  
     MIPA 666 36.43 1301 39.25  1472 40.66  1638 38.76  
     VIPA 943 51.59 1477 44.56  1272 35.14  1005 23.78  
BMI (mean, SD) 25.73 4.43 26.57 4.82 <.0001 27.52 5.36 <.0001 28.66 6.44 <.0001 
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a p-value represents the comparison of variables in individuals with one chronic condition and those who reported 0 chronic 
conditions 
b p-value represents the comparison of variables in individuals with two chronic conditions and those who reported 0 chronic 
conditions 
c p-value represents the comparison of variables in individuals with three or more chronic conditions and those who reported 0 
chronic conditions 
d bold font signifies a significant p-value 
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Figure 4.1: Number of Deaths from All-Cause, Cardiovascular Disease, and Cancer by Multimorbidity Groupinga,b,c,d 
a p-value represents the comparison of variables between individuals who died and had one chronic condition and those who died 
and had 0 chronic conditions 
b p-value represents the comparison of variables between individuals who died and had two chronic conditions and those who died 
and had 0 chronic conditions 
c p-value represents the comparison of variables between individuals who died and had three or more chronic conditions and those 
who died and had 0 chronic conditions 
d * signifies a significant p-value  
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Figure 4.2: Depression Symptom Trajectories by Multimorbidity Classification 
a p-value represents the comparison of variables in individuals with one chronic condition and those who reported 0 chronic 
conditions 
b p-value represents the comparison of variables in individuals with two chronic conditions and those who reported 0 chronic 
conditions 
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c p-value represents the comparison of variables in individuals with three or more chronic conditions and those who reported 0 
chronic conditions 
d bold font signifies a significant p-value 
4
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Figure 4.3: Interaction between Depressive Symptom Trajectories and Multimorbidity on All-Cause Mortality 
a: Adjusted for age, race, education, gender, self-rated health, smoking status, physical activity, and BMI 
0.5 0.7 0.9 1.1 1.3 1.5 1.7 1.9 2.1
D
e
p
re
s
s
io
n
 T
ra
je
c
to
ri
e
s
 
Hazard Ratio and Confidence Intervals 
All Cause Mortalitya 
0 Ref
1
2
3+
0 Ref
1
2
3+
0 Ref
1
2
3+  
  
  
  
  
  
H
IG
H
  
  
  
  
  
  
  
  
  
M
O
D
E
R
A
T
E
  
  
  
  
  
  
  
  
 
L
O
W
 
 
4
2 
 
43 
 
 
Figure 4.4: Interaction between Depressive Symptom Trajectories and Multimorbidity on Cancer Mortality 
a: Adjusted for age, race, education, gender, self-rated health, smoking status, physical activity, and BMI 
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Figure 4.5: Interaction between Depressive Symptom Trajectories and Multimorbidity on CVD Mortality 
a: Adjusted for age, gender, race, education, smoking status, self-rated health, physical activity, and BMI
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CHAPTER 5 
DISCUSSION
 This study was conducted to examine the association depressive symptom 
trajectories coupled with multiple chronic conditions has on all-cause and cause-specific 
mortality. Our results indicated having persistent depressive symptoms, along with 
multiple chronic conditions, can cause an interaction, increasing one’s risk for mortality, 
specifically cardiovascular mortality. Having three or more chronic conditions along with 
persistently high depressive symptoms showed the highest risk of cardiovascular death. 
This leads one to suggest that a dose-response association could be present; illustrated 
by the greater number of chronic conditions one has along with persistently higher 
depressive trajectory scores can lead to the greatest risk of death. Although a clear 
association was seen in cardiovascular mortality, the association between depressive 
symptom trajectories and multimorbidity on all-cause mortality was not as strong. 
Cancer mortality also lacked significance, yet the direction of association was opposite 
of that which was hypothesized.  
Depressive Symptom Trajectories and Multimorbidity on All-Cause Mortality 
 Our results indicate the interaction between multimorbidity and persistent 
depressive symptoms is not significant in predicting all-cause mortality. Although the 
direction indicates a possible association between depressive symptom trajectories, 
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multimorbidity, and all-cause mortality risk, these results did not reach statistical 
significance. In a 2015 study conducted by Gallo and colleagues they analyzed depressed 
and non-depressed patients with medical comorbidity to see if depressed patients had 
an increased risk of all-cause mortality (Gallo et al., 2016). When looking at depressed 
patients receiving usual care practices only those with the highest comorbidity saw a 
significant increase in all-cause mortality, the lower levels of comorbidity did not reach 
statistical significance (Gallo et al., 2016). This result is similar to what we saw in our 
study, as the direction looked to be pointing to an association between depressive 
symptom trajectories and multimorbidity on all-cause mortality, yet did not quite reach 
statistical significance. The lack of significance here could be due to small sample sizes in 
some of the groups being analyzed. Since the study at present just looked at the number 
of conditions an individual has and not the combination of conditions one has, this could 
be a reason for the lack of significance found.  
Depressive Symptom Trajectories and Multimorbidity on Cancer Mortality 
 The results from our study indicate the interaction between depression 
symptom trajectories and number of chronic conditions one has is not predictive for 
cancer mortality. The direction of association for the interaction between depressive 
symptom trajectories and multimorbidity on cancer mortality were slightly negative or 
null. Current literature has shown that depression can cause an increase in mortality, 
however, the role multimorbidity plays in this interaction is not as well understood 
(Giese-Davis et al., 2010; Pinquart & Duberstein, 2010; Satin, Linden, & Phillips, 2009). A 
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study aimed to analyze certain chronic conditions and depression (Gunn et al., 2012). 
This study found after adjusted analyses that depression symptoms was not significantly 
associated with cancer (Gunn et al., 2012). This leads one to hypothesize that 
depression and multimorbidity might not be the driving factor for cancer mortality. 
However, this study only looked at depression during a single measure, so having 
additional studies analyzing depression symptom trajectories is warranted. Other 
factors (treatment, stage, aggressiveness, type) could play a more decisive role in cancer 
mortality than the interaction between depression symptom trajectories and 
multimorbidity. In this current study we did not have information on stage, 
aggressiveness, or type of cancer, which all could play a more critical role in cancer 
mortality 
Depressive Symptom Trajectories and Multimorbidity on Cardiovascular Mortality 
 The results from our study indicate the interaction between depressive symptom 
trajectories and number of chronic conditions is predictive in cardiovascular mortality. 
Regardless of persistent depression status, (low, moderate, high) individuals who had 
three or more chronic conditions saw an increased risk of cardiovascular mortality. 
However, those with persistently high depression symptom trajectories and three or 
more chronic conditions saw the greatest risk for cardiovascular mortality (HR: 1.847; 
95% CI: 1.223-2.789). These results are consistent with previous literature that showed 
depression increased mortality risk in patients with cardiovascular disease (Barefoot et 
al., 1996; Barth, Schumacher, & Herrmann-Lingen, 2004; Frasure-Smith et al., 2009; 
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Penninx et al., 2001; Schulz et al., 2000). In a study among individuals who had 
cardiovascular disease and major depression the risk of mortality was 3.0 times that of 
non-depressed cardiovascular disease patients (Penninx et al., 2001). Our results 
rereinforce the importance of prioritizing cardiovascular disease and depression 
management, as the results are consistently pointing to an increased mortality risk. This 
study shows the potential stratifying cardiovascular multimorbid patients by persistent 
depression status can have in identifying high risk groups for targeted interventions. 
Strengths and Limitations 
 This study has much strength, with one being the diverse, yet nationally 
representative study population. Even with an oversampling of African Americans and 
Hispanics the study population is still highly generalizable for the American population 
(Sonnega et al., 2014). Additionally, this study analyzed depression using trajectory 
methodology which allowed the investigators to see changes in depression symptoms 
over time, reflecting the natural history of the disease (Andreescu et al., 2008; 
Kuchibhatla et al., 2012; Rote, Chen, & Markides, 2015). This measurement method also 
allowed the investigator to identify risk factors and certain outcomes with these 
different trajectories (Hsu, 2012; Musliner et al., 2016). Analyzing how the interaction 
between depressive symptom trajectories and multimorbidity affects cause-specific 
mortality is a strength of this study. The literature on how depressive symptom 
trajectories and multimorbidity affect cause-specific outcomes is lacking. Our study is 
able to provide new light on how depressive symptom trajectories and multimorbidity 
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affects cancer and cardiovascular mortality. Future studies should be conducted to see if 
the associations seen here are replicated in varying populations. An additional strength 
is the methodology involved with dealing with competing risks. Since cardiovascular 
disease and diabetes are competing risks, due to the fact an individual is at risk for more 
than one mutually exclusive event, using a model that accounted for these risks made 
the results more reliable and valid (Gondara, 2015).  Finally, this study had a clear 
temporal order shown, as the exposure status was collected prior to the outcome. 
 Although this study had several strengths it also possesses several limitations. 
Since this study used data from the HRS there is the possibility of recall bias; as some 
participants might recall past illnesses differently than others. For example, someone 
diagnosed with hypertension could potentially recall medical illnesses they have been 
diagnosed with differently than someone without hypertension. A large study was 
conducted in Canada comparing the agreement of self-report data to health 
administrative data on seven chronic conditions: myocardial infarction, asthma, 
diabetes, chronic lung disease, stroke, hypertension, and congestive heart failure 
(Muggah et al., 2013). The researchers found good to very good agreement when 
looking at diabetes and hypertension, moderate agreement for myocardial infarction 
and asthma, and poor agreement for stroke, congestive heart failure, and COPD 
(Muggah et al., 2013). In all cases the prevalence was higher in the health administrative 
data except when looking at myocardial infarction and stroke (Muggah et al., 2013). This 
shows that self-report data is a good tool at looking at some chronic conditions, yet it 
does lack strength in other chronic conditions. There is also a possibility of information 
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bias in this study. Depression has a negative stigma associated with it so individuals 
might not have accurately reported feeling sad or other depressive like qualities. 
Another limitation to this study is the lack of knowledge on disease severity and 
treatment information. We do not know if individuals were properly managing their 
illnesses, or if this would have affected our outcomes. Additionally, we did not adjust for 
pharmacological or non-pharmacological information on depression treatments. There 
was no available information on non-pharmacological treatment methods, and 
pharmacological methods were only available for a sub-sample of the population. 
Finally, covariates were not assessed as time-varying, so covariate status could have 
changed. Although we did not assess confounders as time varying it is believed their effect 
would be minimal as physical activity was one of our potential time varying confounders. 
Physical activity intensity has been shown to decrease with age, so we believe the effects 
potentially shown would have been minimal 
Conclusions 
 It is well known and documented that having an increased number of chronic 
conditions increases your likelihood of mortality. However, the effects depression, 
coupled with having multiple chronic conditions, has on mortality is not as well 
understood. This study found that the interaction between depression and multiple 
chronic conditions can increase ones risk for cardiovascular and diabetes mortality. The 
majority of the study population has more than one chronic condition, consistent with 
the older American population, so it is imperative to properly manage and monitor 
these individuals to help reduce the risk of mortality. Although it has been reported that 
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depressed individuals are more likely to engage in poor management and lifestyle 
choices (lack of medication adherence, more likely to smoke, sedentary lifestyle) a 
randomized controlled trial reported the promising mortality benefits seen in 
depressed, multimorbid patients after receiving chronic disease management (Gallo et 
al., 2016). The mortality benefits seen in Gallo’s study, coupled with the affects seen in 
this current study, highlight the importance chronic disease management could play in 
treating patients with depression and multiple chronic conditions. Additional 
management studies should be conducted to see if the effects are consistent when 
looking at cause-specific mortalities.
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APPENDIX A-SENSITIVITY ANALYSIS 
Table A.1: Distribution of the Number of Chronic Conditions 
 
# of Conditions N % 
0 1833 14.09 
1 3319 25.52 
2 3623 27.86 
3 2374 18.25 
4 1235 9.50 
5 447 3.44 
6 137 1.05 
7 34 0.26 
8 3 0.02 
Totals 13005 100% 
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Table A.2: Distribution of Chronic Conditions by Depression Trajectories 
 
Conditions Low 
(N, %) 
Moderate 
(N, %) 
High 
(N, %) 
0 1378, 10.60 344, 2.65 111, 0.85 
1 2284, 17.56 706, 5.43 329, 2.53 
2 2140, 16.46 936, 7.20 547, 4.21 
3 1193, 9.17 691, 5.31 490, 3.77 
4 485, 3.73 378, 2.91 372, 2.86 
5 103, 0.79 141, 1.08 203, 1.56 
6 17, 0.13 40, 0.31 80, 0.62 
7 2, 0.02 4, 0.03 28, 0.22 
8 0, 0.00 0, 0.00 3, 0.02 
Totals 7602, 58.45 3240, 24.91 2163, 16.63 
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Table A.3: Number of Chronic Conditions by Depression Status for All-Cause Mortality 
 
Conditions No Death (N, %) Death (N, %) 
 Low Moderate High Low Moderate High 
0 1211, 13.52 282, 3.15 83, 0.93 167, 4.12 62, 1.53 28, 0.69 
1 1843, 20.58 545, 6.09 235, 2.62 441, 10.89 161, 3.98 94, 2.32 
2 1576, 17.60 631, 7.05 338, 3.77 564, 13.93 305, 7.53 209, 5.16 
3 752, 8.40 382, 4.27 276, 3.08 441, 10.89 309, 7.63 214, 5.28 
4 245, 2.74 168, 1.88 167, 1.86 240, 5.93 210, 5.19 205, 5.06 
5 40, 0.45 55, 0.61 67, 0.75 63, 1.56 86, 2.12 136, 3.36 
6 6, 0.07 16, 0.18 25, 0.28 11, 0.27 24, 0.59 55, 1.36 
7 1, 0.01 0, 0.00 11, 0.12 1, 0.02 4, 0.10 17, 0.42 
8 0, 0.00 0, 0.00 0, 0.00 0, 0.00 0, 0.00 3, 0.07 
Totals 2674, 63.36 2079, 23.22 1202, 13.42 1928, 47.60 1161, 28.67 961, 23.73 
7
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Table A.4: Number of Chronic Conditions by Depression Status for Cancer Mortality 
 
Conditions No Death (N, %) Death (N, %) 
 Low Moderate High Low Moderate High 
0 114, 3.72 41, 1.34 20, 0.65 53, 5.38 21, 2.13 8, 0.81 
1 312, 10.19 115, 3.76 72, 2.35 128, 12.98 46, 4.67 22, 2.23 
2 406, 13.26 231, 7.54 171, 5.58 157, 15.92 74, 7.51 38, 3.85 
3 333, 10.88 243, 7.94 170, 5.55 108, 10.95 66, 6.69 44, 4.46 
4 176, 5.75 172, 5.62 165, 5.39 64, 6.49 38, 3.85 40, 4.06 
5 49, 1.60 66, 2.16 109, 3.56 14, 1.42 20, 2.03 27, 2.74 
6 9, 0.29 19, 0.62 49, 1.60 2, 0.20 5, 0.51 6, 0.61 
7 1, 0.03 3, 0.10 14, 0.46 0, 0.00 1, 0.10 3, 0.30 
8 0, 0.00 0, 0.00 2, 0.07 0, 0.00 0, 0.00 1, 0.10 
Totals 890, 29.07 1400, 45.72 772, 25.21 526, 53.35 271, 27.48 189, 19.17 
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Table A.5: Number of Chronic Conditions by Depression Status for CVD Mortality 
 
Conditions No Death (N, %) Death (N, %) 
 Low Moderate High Low Moderate High 
0 1328, 11.51 329, 2.85 103, 0.89 48, 3.56 15, 1.11 8, 0.59 
1 2162, 18.75 666, 5.77 305, 2.64 117, 8.67 38, 2.82 23, 1.70 
2 1943, 16.85 831, 7.21 476, 4.13 187, 13.86 100, 7.41 61, 4.52 
3 1019, 8.84 573, 4.97 412, 3.57 159, 11.79 108, 8.01 70, 5.19 
4 387, 3.36 282, 2.45 279, 2.42 83, 6.15 87, 6.45 85, 6.30 
5 75, 0.65 94, 0.82 152, 1.32 26, 1.93 40, 2.97 42, 3.11 
6 14, 0.12 28, 0.24 52, 0.45 3, 0.22 11, 0.82 24, 1.78 
7 2, 0.02 3, 0.03 17, 0.15 0, 0.00 1, 0.07 11, 0.82 
8 0, 0.00 0, 0.00 1, 0.01 0, 0.00 0, 0.00 2, 0.15 
Totals 6930, 60.09 2806, 24.33 1797, 15.58 623, 46.18 400, 29.65 326, 24.17 
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